6 completed, 2 withdrawn, 1 unknown. 6 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 4, Withdrawn 2 |
| Phase 1 | 3 | Completed 2, Unknown 1 |
Follow Saniona: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Tesomet With Open-label Extension in Subjects With Prader-Willi Syndrome Placebo, Tesomet - Prader-Willi Syndrome | Phase 2 | Withdrawn | Saniona | 2021-12-28 | 2022-12-13 | |
| Study of Tesomet With Open-label Extension in Subjects With Hypothalamic Obesity (HO) Placebo, Tesomet - Hypothalamic Obesity | Phase 2 | Withdrawn | Saniona | 2021-11-11 | 2022-12-13 | |
| First-in-human Study of SAN711 in Healthy Participants SAN711, Placebo - Healthy | Phase 1 | Unknown | Saniona | 80 | 2021-06-30 | 2021-07-21 |
| 48 Weeks, Study to Evaluate Overall Safety and Tolerability of Co-administration of Tesofensine and Metoprolol in Subjects With Hypothalamic Injury-induced Obesity (HIO) Tesofensine/Metoprolol, Placebo - Hypothalamic Injury-induced Obesity (HIO) | Phase 2 | Completed | Saniona | 21 | 2019-02-25 | 2024-02-13 |
| A Study to Examine the Effect of Tesofensine and Metoprolol on the 24-hour Mean Heart Rate Metoprolol Succinate 25 MG, Metoprolol Succinate 50 MG, Metoprolol Succinate 100 MG - Phase 1 | Phase 1 | Completed | Saniona | 37 | 2018-07-11 | 2024-02-09 |
| Study to Investigate the Pharmacokinetic Profile Tesomet "High dose" in fasted condition, Tesomet "Low dose" in fasted condition, Comperator 1 mg tesofensine, 25 mg commercial IR metoprolol, 75 mg commercial ER metoprolol, fasted condition. - Healthy Male Subjects | Phase 1 | Completed | Saniona | 60 | 2017-12-18 | 2020-05-14 |
| Co-administration of Tesofensine/Metoprolol in Subjects With Prader-Willi Syndrome (PWS) Tesofensine/Metoprolol, Placebos - Confirmed Genetic Diagnosis of Prader-Willi Syndrome | Phase 2 | Completed | Saniona | 18 | 2017-03-30 | 2024-02-26 |
| Trial Of NS2359 For The Treatment of Cocaine Dependence NS2359, placebo - Cocaine Use Disorder | Phase 2 | Completed | University of Pennsylvania | 55 | 2016-05-01 | 2021-05-24 |
| Safety and Efficacy Study of Tesofensine/Metoprolol Treatment in Subjects With Type 2 Diabetes Mellitus Tesofensine/Metoprolol, Placebo - Type 2 Diabetes Mellitus | Phase 2 | Completed | Saniona | 60 | 2016-04-01 | 2020-05-14 |
Diabetes Mellitus, Type 2 (1) · Hyperphagia (1) · Prader-Willi Syndrome (1) · Sexual Infantilism (1)
Metoprolol (7) · Tesofensine (6) · GSK372475 (1)
Germany (3) · United States (3) · Czechia (1) · Denmark (1) · Hungary (1) · United Kingdom (1)
Kim Krogsgaard, MD, DMSc (2) · Sophie Guillaume, MS (2) · Jorgen Drejer, PhD (1) · Ulla Feldt-Rasmussen, MD, DMSc (1) · Wade Berrettini, MD, PhD (1)